Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06842888 · ClinicalTrials.gov registry record · NA

Comparing Mirror Therapy Rehabilitation Device to Conventional Mirror Therapy

A NA study of Stroke and Pain, sponsored by Yale University.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06842888 is a NA study of Stroke and Pain that has completed, run by Yale University. The registered enrollment target is 24 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06842888, a NA study of Stroke and Pain, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This is a randomized controlled trial which will compare conventional mirror therapy with mirror therapy using the Miraπ device which physically moves a patient's affected limb. This study will use two parallel groups: (1) receiving conventional mirror therapy as a part of the standard of care as conducted by the participant's clinical care team and (2) receiving mirror therapy with the Miraπ device as conducted by study personnel with the oversight of the participant's clinical care team.

Interventions

  • DEVICE Miraπ
  • BEHAVIORAL Mirror Therapy

Study Locations (1)

Connecticut

  • Rehabilitation and Wellness Center at the Milford Campus of Bridgeport Hospital - Milford

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-03-31
Est. Completion 2025-08-19
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT06842888

The ClinicalTrials.gov registry entry for NCT06842888 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Miraπ is the first listed.

NCT06842888 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT06842888 about?

NCT06842888 is a clinical study titled "Comparing Mirror Therapy Rehabilitation Device to Conventional Mirror Therapy". This is a randomized controlled trial which will compare conventional mirror therapy with mirror therapy using the Miraπ device which physically moves a patient's affected limb. This study will use two parallel groups: (1) receiving conventional mirror therapy as a part of the standard of care as c...

What is the current status of trial NCT06842888?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2025-03-31. Estimated completion is 2025-08-19.

What conditions does trial NCT06842888 study?

This clinical trial studies the following conditions: Stroke, Pain, Impaired Motor Function.

What interventions are being tested in trial NCT06842888?

The interventions under investigation include: Miraπ (DEVICE), Mirror Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06842888?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06842888 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.